|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 558.88 USD | +3.50% |
|
+6.67% | +23.28% |
| 06:45pm | Stock Futures Higher, Oil Lower as Investors Return to Risk -- Update | DJ |
| 06:29pm | Stocks Rise Pre-Bell as Traders Look Ahead to Midterm Elections, Fresh Labor Data | MT |
| Market Cap | 14TCr 13TCr 12TCr 11TCr 20TCr 13,45000Cr 20TCr 1,39200Cr 56TCr 7,07500Cr 53TCr 52TCr 22,31300Cr | P/E 2026 * |
33.2x | P/E 2027 * | 30.1x |
|---|---|---|---|---|---|
| Enterprise Value | 13TCr 12TCr 11TCr 10TCr 19TCr 12,71900Cr 19TCr 1,31600Cr 53TCr 6,69000Cr 50TCr 49TCr 21,09900Cr | EV / Sales 2026 * |
10.1x | EV / Sales 2027 * | 9.02x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
Tradegate
| VX1 | Real-time | |
|
Xetra
| VX1 | Delayed | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
London S.E.
| 0QZU | Delayed | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
CBOE
| 0QZU | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +3.50% | ||
| 1 week | +6.67% | ||
| 1 month | +10.29% | ||
| 3 months | +17.14% | ||
| 6 months | +31.84% | ||
| Current year | +23.28% |
| 1 week | 509.2 |  | 563.8 |
| 1 month | 484.08 | | 563.8 |
| Current year | 412.27 | | 563.8 |
| 1 year | 403.16 | | 563.8 |
| 3 years | 341.9 | | 563.8 |
| 5 years | 179.96 | | 563.8 |
| 10 years | 71.46 | | 563.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Agam Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/08/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 27/08/26 | Don | Director | -6,000 | 0.0024% | ||
| 21/07/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.50% | +6.67% | +31.33% | +51.32% | 14TCr | |
| +3.19% | +11.31% | +64.28% | +155.66% | 1,26300Cr | |
| -0.73% | +3.56% | +44.65% | +83.74% | 66TCr | |
| +1.41% | +3.24% | +35.25% | +106.98% | 52TCr | |
| -1.72% | +0.10% | +52.95% | +66.66% | 39TCr | |
| +2.18% | +2.93% | +73.90% | +45.38% | 37TCr | |
| -1.77% | +3.12% | +32.12% | +55.28% | 31TCr | |
| -1.60% | +7.08% | +11.32% | +32.83% | 29TCr | |
| +1.15% | +6.09% | +56.15% | +78.66% | 25TCr | |
| +3.06% | +9.38% | +42.48% | +112.84% | 21TCr | |
| Average | +0.24% | +5.98% | +44.44% | +78.94% | 44.04TCr | |
| Weighted average by Cap. | -0.29% | +6.60% | +49.41% | +97.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33TCr 1.19TCr 1.09TCr 991.34Cr 1.85TCr 1,26100Cr 1.89TCr 13TCr 5.24TCr 66TCr 4.98TCr 4.88TCr 2,09200Cr | 1.46TCr 1.31TCr 1.2TCr 1.09TCr 2.04TCr 1,38600Cr 2.08TCr 14TCr 5.76TCr 73TCr 5.48TCr 5.36TCr 2,30000Cr |
| Net income | 437.57Cr 391.89Cr 360.47Cr 326.62Cr 610.53Cr 42TCr 621.96Cr 4.3TCr 1.73TCr 22TCr 1.64TCr 1.61TCr 69TCr | 486.71Cr 435.9Cr 400.95Cr 363.3Cr 679.09Cr 46TCr 691.81Cr 4.78TCr 1.92TCr 24TCr 1.83TCr 1.79TCr 77TCr |
| Net Debt | -770.4Cr -689.97Cr -634.66Cr -575.05Cr -1.07TCr -73TCr -1.1TCr -7.57TCr -3.04TCr -38TCr -2.89TCr -2.83TCr -1,21300Cr | -1TCr -897.14Cr -825.23Cr -747.72Cr -1.4TCr -95TCr -1.42TCr -9.84TCr -3.95TCr -50TCr -3.76TCr -3.68TCr -1,57800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $558.88 | +3.50% | 30,30,027 |
| 29/26/29 | $540.00 | +1.95% | 15,42,075 |
| 28/26/28 | $529.69 | +1.66% | 12,84,581 |
| 27/26/27 | $521.03 | +0.68% | 10,19,888 |
| 26/26/26 | $517.49 | -1.23% | 11,89,035 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
